Houston Texans wide receiver Stefon Diggs has faced growing speculation about where he could land next season, but the All-Pro was embroiled in a different kind of rumor this week. Diggs was ...

Just days before the Super Bowl, Cardi B is making headlines—not for new music or Offset-related drama, but for stepping out with NFL star Stefon Diggs. Back in October 2024, rumors of a ...

One of the big storylines surrounding the Houston Texans entering the NFL offseason has to do with the future of star veteran wide receiver Stefon Diggs. After making a big trade last offseason to ...

Prior to arriving in Houston, Diggs posted four straight 100-catch, 1000-yard campaigns with the Buffalo Bills. Oct 13, 2024; Foxborough, Massachusetts, USA; Houston Texans wide receiver Stefon ...

The 2024 NFL season drew to a close with the Philadelphia Eagles decimating the Kansas City Chiefs in Super Bowl LIV. Many ...

The Eagles have always spent under Jeffrey Lurie, but this season was different. Plus, why time might not be on Patrick ...

Getty Images Pharmaceutical company Eli Lilly is expected to report fourth-quarter earnings before the bell Thursday. Analysts tracking the company see increased sales and profit for Eli Lilly in ...

Eli Manning was obviously snubbed by missing out on the Pro Football Hall of Fame class of 2025, but the former New York Giants great is taking it well. In fact, he had a really classy reaction to ...

It was an honor many thought would go to Peyton and Eli Manning, who missed out on the Hall of Fame Tuesday night. "Sterling and Shannon Sharpe are the first brothers to both be inducted into the ...

It’s the smallest Hall of Fame class in 20 years. Not making the cut: Eli Manning. The former New York Giants quarterback, a two-time Super Bowl MVP, was bypassed by the 49-member selection ...

Eli Manning will have to wait to get into the Pro Football Hall of Fame for at least another year. The legendary New York Giants quarterback didn't make the cut for the Class of 2025 in his first ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.